These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38400888)

  • 1. Efficacy of leuprorelin in spinal and bulbar muscular atrophy: a 3-year observational study.
    Kang MG; Kang M; Cho HJ; Min YS; Park JS
    Neurol Sci; 2024 Aug; 45(8):3853-3859. PubMed ID: 38400888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of leuprorelin in bulbar function of spinal and bulbar muscular atrophy patients: observational study for 1 year.
    Kang MG; Gwak DW; Cho HJ; Min YS; Park JS
    J Neurol; 2021 Sep; 268(9):3344-3351. PubMed ID: 33675422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial.
    Katsuno M; Banno H; Suzuki K; Takeuchi Y; Kawashima M; Yabe I; Sasaki H; Aoki M; Morita M; Nakano I; Kanai K; Ito S; Ishikawa K; Mizusawa H; Yamamoto T; Tsuji S; Hasegawa K; Shimohata T; Nishizawa M; Miyajima H; Kanda F; Watanabe Y; Nakashima K; Tsujino A; Yamashita T; Uchino M; Fujimoto Y; Tanaka F; Sobue G;
    Lancet Neurol; 2010 Sep; 9(9):875-84. PubMed ID: 20691641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.
    Banno H; Katsuno M; Suzuki K; Takeuchi Y; Kawashima M; Suga N; Takamori M; Ito M; Nakamura T; Matsuo K; Yamada S; Oki Y; Adachi H; Minamiyama M; Waza M; Atsuta N; Watanabe H; Fujimoto Y; Nakashima T; Tanaka F; Doyu M; Sobue G
    Ann Neurol; 2009 Feb; 65(2):140-50. PubMed ID: 19259967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials.
    Hashizume A; Katsuno M; Suzuki K; Banno H; Takeuchi Y; Kawashima M; Suga N; Mano T; Araki A; Hijikata Y; Hirakawa A; Sobue G;
    J Neurol; 2019 May; 266(5):1211-1221. PubMed ID: 30847645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Effects of Androgen Deprivation in a Patient with Spinal and Bulbar Muscular Atrophy - A Case Report with 14 Years of Follow-up.
    Hijikata Y; Hashizume A; Yamada S; Ito D; Banno H; Suzuki K; Sobue G; Katsuno M
    Intern Med; 2019 Aug; 58(15):2231-2234. PubMed ID: 30996158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study.
    Hashizume A; Katsuno M; Suzuki K; Hirakawa A; Hijikata Y; Yamada S; Inagaki T; Banno H; Sobue G
    J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1026-1032. PubMed ID: 28780536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and Validity of the Korean Version of the Spinal and Bulbar Muscular Atrophy Functional Rating Scale.
    Oh SI; Oh J; Park D; Son K; Park JS
    J Clin Neurol; 2020 Oct; 16(4):586-591. PubMed ID: 33029964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study.
    Hashizume A; Katsuno M; Suzuki K; Banno H; Suga N; Mano T; Araki A; Hijikata Y; Grunseich C; Kokkinis A; Hirakawa A; Watanabe H; Yamamoto M; Fischbeck KH; Sobue G
    Neuromuscul Disord; 2015 Jul; 25(7):554-62. PubMed ID: 25913211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
    Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
    Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troponin T in spinal and bulbar muscular atrophy (SBMA).
    Musso G; Blasi L; Mion MM; Fortuna A; Sabbatini D; Zaninotto M; Bello L; Pegoraro E; Basso D; Plebani M; Sorarù G
    J Neurol Sci; 2024 Jan; 456():122816. PubMed ID: 38071852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)].
    Suzuki K; Banno H; Katsuno M; Adachi H; Tanaka F; Sobue G
    Brain Nerve; 2012 Mar; 64(3):237-44. PubMed ID: 22402717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA).
    Blasi L; Sabbatini D; Fortuna A; Querin G; Martinelli I; Vianello S; Bertolin C; Pareyson D; Pennuto M; Pegoraro E; Bello L; Sorarù G
    Sci Rep; 2023 Oct; 13(1):17311. PubMed ID: 37828349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open trial of long-term testosterone suppression in spinal and bulbar muscular atrophy.
    Yamamoto T; Yokota K; Amao R; Maeno T; Haga N; Taguri M; Ohtsu H; Ichikawa Y; Goto J; Tsuji S
    Muscle Nerve; 2013 Jun; 47(6):816-22. PubMed ID: 23512333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker.
    Banno H; Adachi H; Katsuno M; Suzuki K; Atsuta N; Watanabe H; Tanaka F; Doyu M; Sobue G
    Ann Neurol; 2006 Mar; 59(3):520-6. PubMed ID: 16358333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy.
    Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
    Int J Mol Sci; 2009 Mar; 10(3):1000-12. PubMed ID: 19399234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary design and validation of the "6-K-scale" for bulbar symptoms evaluation in SBMA.
    Giorgia Q; Irene B; Laura M; Ilaria M; Cinzia B; Elena P; Sorarù G
    Neurol Sci; 2019 Jul; 40(7):1393-1401. PubMed ID: 30915613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combined Efficacy of a Two-Year Period of Cybernic Treatment With a Wearable Cyborg Hybrid-Assistive Limb and Leuprorelin Therapy in a Patient With Spinal and Bulbar Muscular Atrophy: A Case Report.
    Nakatsuji H; Ikeda T; Hashizume A; Katsuno M; Sobue G; Nakajima T
    Front Neurol; 2022; 13():905613. PubMed ID: 35812096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasometric Scores in spinal and bulbar muscular atrophy - Effects of palatal lift prosthesis on dysarthria and dysphagia.
    Tanaka S; Hashizume A; Hijikata Y; Yamada S; Ito D; Nakayama A; Kurita K; Yogo H; Banno H; Suzuki K; Yamamoto M; Sobue G; Katsuno M
    J Neurol Sci; 2019 Dec; 407():116503. PubMed ID: 31669728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of spinal and bulbar muscular atrophy with high-stage and high-Gleason Score prostate cancer responded to maximal androgen blockade therapy.
    Kosaka T; Miyajima A; Kikuchi E; Takahashi S; Suzuki N; Oya M
    J Androl; 2012; 33(4):563-5. PubMed ID: 21940987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.